Breast Cancer Recurrence Risk Calculator

Written by Great Medico

Updated September 24, 2026 •2 min read

Share Print Save

Breast-cancer recurrence risk cannot be reduced to one number, but a structured score can show what this simplified model is actually counting. Breast Cancer Recurrence Risk Calculator keeps its limited tumor features and result explicit.

What this calculator does

Breast Cancer Recurrence Risk Calculator uses Tumor grade, Lymph-node involvement, and Lymphovascular invasion to calculate the simplified breast-cancer recurrence component score. It is built around the exact fields displayed in this plugin rather than a generic version of the topic. This is a simplified oncology score, not a fertility or pregnancy estimate. Pathology details, tumor biology, treatment, stage, and current oncology risk models can materially change recurrence assessment.

How to use it

Enter or select Tumor grade, Lymph-node involvement, and Lymphovascular invasion. Use the units offered by the calculator and choose the option that matches the actual clinical or timing situation. Check date entries and laboratory units before relying on the output. Use verified pathology, history, and demographic information from the same clinical assessment rather than estimates when those records are available.

How the calculation works

This build adds the point values represented by tumor grade, lymph-node category, and lymphovascular-invasion status and returns a recurrence-risk component score. It does not convert that score into a precise recurrence probability because the historical model behind these fields is simplified and not a substitute for modern multivariable oncology risk assessment.

Example

Using the sample values prefilled in this calculator, the primary result is 2 points (Recurrence-risk component score). This worked example shows how the plugin’s own default inputs flow through the implemented method; replace them with the correct patient, laboratory, imaging, or personal values before interpreting a result.

How to interpret the result

Read this as the simplified recurrence component score produced from the three tumor features entered. It is not a recurrence percentage and should not be mapped to treatment or prognosis without a current oncology model and the full pathology context.

Limitations and notes

This plugin deliberately reports only the simplified component score. Modern recurrence assessment incorporates tumor size/stage, receptor and HER2 biology, genomic assays when indicated, systemic therapy, radiation, margins, nodal details, and patient factors. Do not translate this score into a treatment decision.